If you have heart failure, the right treatment can make all the difference in improving your symptoms and extending your life. Treatments range from lifestyle changes like cutting back on salt to a ...
You've probably heard or read about congestive heart failure. Maybe you've even been told you have it, or know someone who ...
Physician-scientists announced today the results of the largest cell therapy trial to date in patients with chronic heart failure due to low ejection fraction. The therapy benefited patients by ...
XYRA LLC announces that the US Patent and Trademark Office (USPTO) has issued a patent (No. 12,551,706) protecting the use of dose adjusted budiodarone for the treatment of atrial fibrillation (AF), ...
Panelists discuss how effective heart failure management requires collaborative care across multiple specialties (primary care, cardiology, endocrinology, nephrology) with advanced practice providers ...
You can follow a treatment plan and take medications as a doctor prescribes to manage congestive heart failure. Eat a heart-healthy diet and stay physically active to slow heart failure progression.
Barriers to optimal heart failure treatment are broken down by the expert panelists. This is a video synopsis/summary of a panel discussion involving Robert Groves, MD; Eugene E. Wright Jr, MD; Nancy ...
Approximately 6.7 million Americans over the age of 20 currently live with heart failure, with this number projected to rise to 8.5 million by 2030. The lifetime risk of developing heart failure has ...
Japan has approved two pioneering stem-cell therapies for the treatment of Parkinson’s disease and severe heart failure, marking a major milestone in ...
TULSA, Okla. — Some people with congestive heart failure are getting the chance to try a new treatment. Saint Francis is in the middle of a two-year double-blind clinical trial for a device that could ...
There were 928 patients with CHF (i.e., International Classification of Diseases, 9th Revision, Clinical Modification codes 428, 402.01, 402.11,402.91, and 404) admitted to our institution between ...